Top

Journal of General Internal Medicine

Published in:

01-03-2008 | Original Article

Patients’ Beliefs and Preferences Regarding Doctors’ Medication Recommendations

Authors: Sarah L. Goff, MD, Kathleen M. Mazor, PhD, Vanessa Meterko, BS, Katherine Dodd, BS, James Sabin, MD

Published in: Journal of General Internal Medicine | Issue 3/2008

Abstract

Background

An estimated 20–50% of patients do not take medications as recommended. Accepting a doctor’s recommendation is the first step in medication adherence, yet little is known about patients’ beliefs and preferences about how medications are prescribed.

Objective

To explore patients’ beliefs and preferences about medication prescribing to understand factors that might affect medication adherence.

Methods

Fifty members from 2 health plans in Massachusetts participated in in-depth telephone interviews. Participants listened to an audio-vignette of a doctor prescribing a medication to a patient and were asked a series of questions related to the vignette. Responses were reviewed in an iterative process to identify themes related to participants’ beliefs and preferences about medication prescribing.

Results

Participants’ beliefs and preferences about medication prescribing encompassed 3 major areas: patient–doctor relationships, outside influences, and professional expertise. Important findings included participants’ concerns about the pharmaceutical industry’s influence on doctors’ prescribing practices and beliefs that there is a clear “best” medication for most health problems.

Conclusions

Patients’ beliefs and preferences about medication prescribing may affect medication adherence. Additional empiric studies that explore whether doctors’ relationships with pharmaceutical representatives impact medication adherence by affecting trust are indicated. In addition, it would be worthwhile to explore whether discussions between patients and doctors regarding equipoise (no clear scientific evidence for 1 treatment choice over another) affect medication adherence.

Available only for authorised users

Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005;353:487–97.PubMedCrossRef

Col N, Fanale JE, Kronholm P. The role of medication non-compliance and adverse drug reactions in the hospitalizations of the elderly. Arch Int Med. 1990;150:841–45.CrossRef

McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharacother. 2002;36:1331–36.CrossRef

Chan M, Niklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Internal Med J. 2001;31:199–205.CrossRef

Kaiser Commonwealth/Tufts New England Medical Center. National Survey of Seniors and Prescription Drugs. Boston, MA: Kaiser Commonwealth/Tufts New England Medical Center; 2003.

Schneider J, Kaplan SH, Greenfield S Li W, Wilson IB. Better patient-doctor relationships are associated with higher reported adherence to antiretroviral therapy in HIV patients. J Gen Intern Med. 2004;19:1096–1103.PubMedCrossRef

Falvo D, Woehlche P Dichmann J. Relationship of doctor behavior to patient compliance. Patient Couns Health Educ. 1980;2:185–88.PubMedCrossRef

Hulka BS, Cassel JC, Kupper LL Burdette JA. Communication compliance and concordance between patients and doctors with prescribed medications. Am J Public Health. 1976;66:847–53.PubMedCrossRef

Agency for Helathcare Research Quality. Quick tips—When Getting a Prescription. AHRQ Publlication 01-0040c. Rockville, MD: Agency for Helathcare Research Quality; 2002 May.

10.

Tarn DM, Heritage J, Paterniti D, Hays , Kravitz , Wenger N. Doctor communication when prescribing new medications. Arch Int Med. 2006;166:1855–62.CrossRef

11.

Finch J. The vignette technique in survey research. Sociology. 1987;2:105–114.CrossRef

12.

Hughes R. Considering the vignette technique and its application to a study of drug injecting and HIV risk and safer behaviour. Sociol Health Illn. 1998;20:381–400.CrossRef

13.

Gibbons RJ, Robert V, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey C, Kroenke K. A comparison of patients’ and doctors’ attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151–4.PubMedCrossRef

14.

Blake RL, Early EK. Patients’ attitudes about gifts to doctors from pharmaceutical companies. J Am Board Fam Pract. 1995;8:457–64.PubMed

15.

Semin S, Guldal D, Ozcar N, Mevsim V. What patients think about promotional activities of the pharmaceutical industry in Turkey. Pharm World Sci. 2006;48:513–21.

16.

Wazana A. Is a gift ever just a gift? JAMA. 2000;283:373–80.PubMedCrossRef

17.

Chren MM, Landefeld CS. Doctors’ behavior and their interactions with drug companies. A controlled study of doctors who requested additions to a hospital drug formulary. JAMA. 1994;271:684–89.PubMedCrossRef

18.

Brennan TA, Rothman DJ, Blank L, et al. Health Industry Practices that Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers. JAMA. 2006;295:429–33.PubMedCrossRef

19.

Blumenthal D. Doctors and Drug Companies. N Engl J Med. 2004;351:1885–90.PubMedCrossRef

20.

Petersen M. Court papers suggest scale of drugs use: lawsuit says doctors were paid endorsers. NY Times. May 30, 2003:C1–C2.

21.

Harris G. As doctor writes prescription, drug company writes check. NY Times. June 17, 2004 :A1–A19.

22.

Pollock A. Stanford to ban drug makers’ gifts to doctors, even pens. NY Times. September 12, 2006.

23.

Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291:2359–66.PubMedCrossRef

24.

Elwyn G, Edwards A, Kinnersley P, Grol R. Shared decision making and the concept of equipoise: the competencies of involving patients in health care choices. Br J Gen Pract. 2000;50:892–9.PubMed

25.

Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003 Aug 20;290(7):953–8.CrossRef

26.

Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of the Veteran’s Administration. AM J Med. 2007;120:26–32.PubMedCrossRef

27.

Charles H, Good CB, Hanusa BH, Chang C, Whittle CJ. Racial differences in adherence to cardiac medications. J Natl Med Assoc. 2003;95:17–27.PubMed

28.

Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.PubMedCrossRef

29.

Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK, et al. Racial differences in blood pressure control; potential explanatory factors. Am J Med. 2006;119:e9–15.PubMed

30.

Li XM. Traditional Chinese herbal remedies for asthma and food allergy. J Allergy Clin Immunol. 2007;120(1):25–31.PubMedCrossRef

31.

George J, Kong DC, Thoman, Stewart K. Factors associated with medication non-adherence in patients with COPD. Chest. 2005;128:3198–204.PubMedCrossRef

32.

Van Sickle D, Wright AL. Navajo perceptions of asthma and asthma medications: clinical implications. Pediatrics. 2001;108(1):E11 Jul.PubMedCrossRef

Title: Patients’ Beliefs and Preferences Regarding Doctors’ Medication Recommendations
Authors: Sarah L. Goff, MD
Kathleen M. Mazor, PhD
Vanessa Meterko, BS
Katherine Dodd, BS
James Sabin, MD
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Journal of General Internal Medicine / Issue 3/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-007-0470-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2008

Leveraging Primary Care in the Fight Against Lung Cancer

Communicating about Alcohol Consumption to Nonharmful Drinkers with Hepatitis C: Patient and Provider Perspectives

The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry

Self-reported Halitosis and Gastro-esophageal Reflux Disease in the General Population

An Intervention to Improve Procedure Education for Internal Medicine Residents

Answered Prayer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials